Chad M Kormos

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Structure Activity Relationship

High Throughput

Binding Protein

Anti Inflammatory

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

University of Connecticut (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Connecticut

United States

PHD :: Chemistry

Worcester Polytechnic Institute

United States

BSC :: Chemistry

Publications

Anita H Lewin, James P Hayes, Desong Zhong, Dehui Zhang, Chad M Kormos, S Wayne Mascarella, Herbert H Seltzman
Isolation of Hemiketal and Hydroxy Ketone Tautomers of Synthetic Intermediates Each Affording 18-Hydroxycortisol- 1,6,7-d 3 . ACS omega 8 (31) (2023)
Ann M Decker, Marcus F Brackeen, Aida Mohammadkhani, Chad M Kormos, David Hesk, Stephanie L Borgland, Bruce E Blough
Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist. ACS chemical neuroscience 13 (7) (2022)
Pauline W Ondachi, Chad M Kormos, Scott P Runyon, James B Thomas, S Wayne Mascarella, Ann M Decker, Hernán A Navarro, Timothy R Fennell, Rodney W Snyder, F Ivy Carroll
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic). Journal of medicinal chemistry 61 (17) (2018)
Chad M Kormos, Pauline W Ondachi, Scott P Runyon, James B Thomas, S Wayne Mascarella, Ann M Decker, Hernán A Navarro, Timothy R Fennell, Rodney W Snyder, F Ivy Carroll
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic). Journal of medicinal chemistry 61 (17) (2018)